Anthim obiltoxaximab: Phase III data

An open-label, U.S. Phase III trial in 40 healthy adult volunteers showed that the addition of ciprofloxacin to a single dose

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE